Precigen gains after 2025 results on Papzimeos outlook [Seeking Alpha]
Precigen, Inc. (PGEN)
Last precigen, inc. earnings: 3/2 04:05 pm
Check Earnings Report
Company Research
Source: Seeking Alpha
welcomed the immunotherapy developer's outlook for Q1, boosted by its recently launched tumor therapy Papzimeos. PGEN's Earnings Call Insights: Here's what you need to know On Wednesday in the aftermarket, the Maryland-based biotech reported $9.7M in Newsletters for Every Investor Get daily, sector-specific newsletters packed with expert insights, fresh ideas, and new opportunities. Subscribe to Newsletters Sign Up Quick Insights Papzimeos showed robust uptake with Q1 revenue guidance above consensus, leading analysts to view its commercial momentum and early launch metrics positively. Precigen missed revenue consensus, posted a widened net loss, and saw increased expenses, mainly due to the Papzimeos launch costs. Analysts highlight Papzimeos' favorable IP protection, broad growth opportunities, and potential to become a franchise product. Recommended For You More Trending News
Show less
Read more
Impact Snapshot
Event Time:
PGEN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PGEN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PGEN alerts
High impacting Precigen, Inc. news events
Weekly update
A roundup of the hottest topics
PGEN
News
- Discover Precigen And 2 Other Insider-Favored Growth Stocks [Yahoo! Finance]Yahoo! Finance
- Is It Too Late To Consider Precigen (PGEN) After Its 145% One Year Surge? [Yahoo! Finance]Yahoo! Finance
- Precigen (PGEN) had its price target raised by Citizens Jmp from $8.00 to $9.00. They now have a "market outperform" rating on the stock.MarketBeat
- Precigen (PGEN) had its price target raised by HC Wainwright from $9.00 to $10.00. They now have a "buy" rating on the stock.MarketBeat
- Precigen Inc (PGEN) Q4 2025 Earnings Call Highlights: Revenue Surge and Strategic Expansion ... [Yahoo! Finance]Yahoo! Finance
PGEN
Earnings
- 3/25/26 - Miss
PGEN
Sec Filings
- 3/25/26 - Form 10-K
- 3/25/26 - Form 8-K
- 3/20/26 - Form 4
- PGEN's page on the SEC website